Cargando…
Sleep Duration and “on” Time during Different Periods of the Day and Night in Patients with Advanced Parkinson's Disease Receiving Adjunctive Ropinirole Prolonged Release
Patients undergoing long-term therapy for PD often experience motor fluctuations and nocturnal disturbances. In a post-hoc analysis, we explored effects of ropinirole prolonged release on sleep, night-time awakenings, and “on” time over 24 hours. Patients with advanced PD suboptimally controlled wit...
Autores principales: | Reichmann, Heinz, Cooper, James, Rolfe, Katie, Martinez-Martin, Pablo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE-Hindawi Access to Research
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3109339/ https://www.ncbi.nlm.nih.gov/pubmed/21687750 http://dx.doi.org/10.4061/2011/354760 |
Ejemplares similares
-
A review of ropinirole prolonged release in Parkinson’s disease
por: Nashatizadeh, Muhammad M, et al.
Publicado: (2009) -
Comparison of once-daily versus twice-daily combination of Ropinirole prolonged release in Parkinson’s disease
por: Yun, Ji Young, et al.
Publicado: (2013) -
Comparison of long‐term use of prolonged‐release ropinirole and immediate‐release dopamine agonists in an observational study in patients with Parkinson's disease
por: Gungabissoon, Usha, et al.
Publicado: (2020) -
Update on ropinirole in the treatment of Parkinson’s disease
por: Shill, Holly A, et al.
Publicado: (2009) -
Nanotechnology-based drug delivery of ropinirole for Parkinson’s disease
por: Barcia, Emilia, et al.
Publicado: (2017)